Students to get hands-on experience through summer programJune 26, 2019More than 200 students from 42 veterinary schools in the U.S. and beyond will forego vacation this summer to work in laboratories with academic and industry leaders.
SPONSORED CONTENTStart Treating Canine MMVD Patients at Stage B2Learn about early treatment with pimobendan for canine Stage B2 preclinical MMVD patients. + Learn More
Boehringer Ingelheim launches initiative to fight heartworm disease in dogsMarch 6, 2019Boehringer Ingelheim is debuting Heartworm 2020, an initiative dedicated to increasing the number of dogs who receive heartworm disease prevention in 2019. The initiative comes in response to a report from the American Heartworm Society (AHS) that found a 21 percent increase in positive heartworm tests per clinic. "We knew we could help increase the number of dogs receiving the heartworm disease prevention," says Sarah Cloud, Heartgard brand director. "Heartworm 2020 addresses this issue …
Boehringer Ingelheim announces North American headquarters in GeorgiaFebruary 27, 2019Boehringer Ingelheim has announced it is investing $120 million in Georgia, creating 225 jobs. "For nearly 40 years, the company and its predecessors have helped make the state of Georgia a key player in animal health—from its beginning producing rabies vaccines in Athens, to multiple facilities today that are playing an instrumental role in advancing animal health and well-being," said Everett Hoekstra, president of Boehringer Ingelheim Animal Health USA. "Our investments will expand our capabilities …
FDA approves Boehringer Ingelheim's Semintra for feline hypertensionOctober 2, 2018The U.S. Food & Drug Administration has approved Semintra (telmisartan oral solution) 10 mg/mL oral solution for the control of systemic hypertension in cats, according to Boehringer Ingelheim. The product was designed specifically with cats in mind to provide safe, reliable, and convenient long-term control of blood pressure, said Boehringer Ingelheim. "We are proud to continue to set new standards of care for cats to optimize their health and well-being through the veterinarian," said …
Boehringer Ingelheim gives support shots for World Rabies Day 2018September 13, 2018Merial, part of Boehringer Ingelheim (BI), announced it will donate 75,000 doses of rabies vaccine to the Global Alliance for Rabies Control (GARC) in recognition of World Rabies Day on Sept. 28. The donation is a result of the Shots for Good initiative, in which BI pledged to donate doses of rabies vaccine for every dose of Purevax, Recombitek, and Imrab vaccine purchased by participating …
Kindred Biosciences joins AAEP educational partnersSeptember 4, 2018Kindred Biosciences Inc. has joined the American Association of Equine Practitioners' (AAEP) Educational Partner Program. Educational Partners provide resources and education through the AAEP to equine veterinarians and horse owners to improve animal health and welfare. "KindredBio's partnership with the AAEP brings together two organizations that share a passion for improving equine wellness," said Denise Bevers, co-founder and COO. "Our company is focused on addressing the numerous unmet …
Boehringer Ingelheim receives new label claim for repro productAugust 29, 2018Boehringer Ingelheim announced that Cystorelin is now labeled for use in combination with Synchsure to synchronize estrous cycles to allow for fixed-time artificial insemination in lactating dairy cows and beef cows. When used together, the products can provide producers with shortened time to first service, increased estrus-detection efficiency, and improved first-service conception rate in their cattle. "Cystorelin and Synchsure deliver dependability and flexibility that can improve overall herd reproductive performance," Stephen Foulke, DVM, professional …
FDA approves NexGard expanded label claimsAugust 22, 2018Merial, part of Boehringer Ingelheim, received approval from the U.S Food and Drug Administration to expand the label claims for NexGard (afoxolaner). The flea and tick control product is now approved to prevent Borrelia burgdorferi infections as a direct result of it killing Ixodes scapularis vector ticks, commonly called black-legged, or deer, ticks. NexGard is the first and only flea and tick product to receive FDA approval for preventing infections that cause Lyme disease …
Veterinary practice trends webinar highlights further industry consolidationAugust 17, 2018In just five years, 25 percent of veterinary practices, accounting for half of all veterinary visits, will be corporately owned, according to Brakke Consulting. During a webinar presented at the end of June, "Hot Topics in Veterinary Practice," Brakke senior consultant John Volk said myriad variables were contributing to the trend: looming mass veterinarian retirement, fewer vets wanting to own practices, low interest rates and high interest for investors, and more. …
Meet the 2018 National Veterinary Scholars award recipientsAugust 7, 2018The 29th annual National Veterinary Scholars Symposium drew more than 650 veterinary students from across North America and Europe, animal health researchers, and leaders from more than 36 veterinary schools, to view research accomplishments by veterinary students completing summer research internships. The Boehringer Ingelheim-sponsored program, which allows veterinary schools to introduce first- and second-year veterinary medical students to biomedical research, was held Aug. 4-5 at Texas A&M University. Presentations and panel discussions provided students with …
